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ABSTRACT 
131 
Spirometra erinaceieuropaei is extensively distributed in the wor1d and infects domestic and 
wi1d cats and dogs. Plerocercoids are able to infect species of al c1asses of vertebrates ex-
cept fishes and cause important zoonoses in the human， but have been noticed because of 
their ability to produce and release a substance， plerocercoid growth factor (PGF)， which 
binds and activates growth hormone (GH) receptors， resulting in accelerated growth of the 
host. The mice， inc1uding Snell dwarf mice， hypothyroid mice， which were infected with 
plerocercoids had accelerated growth with an increase in the number of the infected 
plerocercoids. Plerocercoid infection stimulated the incorporation of :JH-thymidine andおS-
sulfate in costal cartilages of Snell dwarf mice， resulting in the proliferation of the car-
tilage. Plerocercoids， however， decrease in the GH content in the hypophysis and the 
thyroxine and triiodothyronine levels in the serum of mice. Furthermore， the serum from 
plerocercoid-infected mice increased in the incorporation of :JH-thymidine in cultur・edmouse 
parenchymal hepatocytes and the extract of plerocercoids displaced 12iiI-human GH from its 
receptor on hepatic membranes prepared from a pregnant rabbit. Therefore， PGF produced 
by plerocercoids was considered to mimic the physiological actions of GH in the host. This 
PGF was purified from the extract of plerocercoids as 27 kDa glycoprotein， using GH 
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receptor-affinity chromatography and ge1 filtration， and then cross-reacted against the anti-
human GH (hGH) monoclona1 antibody. A partia1 amino acid sequence of this protein 
showed the homo1ogy of 67% to cathepsin-L. In addition， this protein stimu1ated pro1ifera-
tion of the cu1tured mouse parenchyma1 hepatocytes and this abi1ity was inhibited by the 
addition of E64 which was a specific cystein proteinase inhibitor. We are investigating func-
tions of this 27 kDa glycoprotein in host-parasite re1ationship. Our findings on the ro1e of 
27 kDa glycoprotein clarifed are as follows; 
1. The cDNA of 27 kDa protein was constituted with 1085-bp in 1ength containing an open 
reading frame of l008-bp encording 336 amino acids. The amino acids sequence predict-
ed from the cDNA did not show the homo1ogy to that of hGH but showed the homo1o-
gy of 65% to that of mouse cathepsin-L. 
2. 27 kDa protein cleavaged human IgG and then the worm extract containing this protein 
a1so cleavaged anti-27 kDa protein po1yclona1 antibody. 
3. 27 kDa protein showed the trypsin inhibitory activity. 
4. 27 kDa protein was extensive1y distributed over the surface of the p1erocercoid body， 
and therefore， ithas ro1es to evade from the attack of the antibody and digestion in the 
host intestine. Furthermore， this protein must be usefu1 to penetrate tissues for invasion 
into their hosts. (Accepted on J une 3， 1999) 
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子， plerocercoid growth factor (PGF)によって
生ずることが示唆された.さらに，感染血清およ




































からmRNAを抽出し， SuperScript™ Plasmid 
System Kit (Gmco)を用い， vectodこpSPORT1 
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Fig. 2. Comparison of amino acid sequences of PGF from plerocercoids of S. 
erinaceieuropaei (PGF-E)， S. mansonoides (PGF-M)， mouse cathepsin-L (M 



















Triton X -100加25mM Tris-HC1 buffer p註 7.6
で抽出し 105g上清を抽出液とし，抽出液また
は精製27kDa糖蛋白を試料とした. 10 mM 
EDTA加25mM Tris-HC1 buffer pH 7.4に溶解
した0.5μg/m1のピオチン化抗ーヒトIgG(hIgG) 
抗体を虫体抽出液または27kDa糖蛋白と370C，




Purification Kit (Bio-Rad Lab.)にて精製し，抗
マンソン裂頭条虫擬充尾虫が産生する成長ホルモン様因子の意義 135 
-27 kDa抗体を作成した この19G抗体をHarlow
et al. (1988) 18)の方法でビオチン化した.このビ
オチン化抗 27kDa抗体に対して虫体抽出液また
はE64，1eupeptin， pepstatin処理された虫体抽出




















を含む生理食塩水で、4回洗浄した後， 24 wel mu1ti 
dishでl隻の擬充尾虫を1251-抗27kDa抗体を含む
1 m1のDu1becco'smodified essentia1 mediumで

























ton X-I00を含む25mM Tris-HC1 buffer pH 









Fig. 4. Effect of 27 kDa protein and worm extract on the biotynilated anti-hu-
man IgG antibody. 
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Fig. 5. Effect of the worm extract on the biotynilated anti-27 kDa antiboby 
Lane 1: IgG， Lane 2:worm extract， Lane 3: IgG added worm extract， Lane 4: IgG 
added worm extract incubated with E64， Lane 5: IgG added worm extract incubated 
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Fig. 6. Incorporation of 1251-anti-27 kDa protein antibody into plerocercoids 
during various incubation times. 
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Fig. 7. Incorporation of 1251-anti-27 kDa protein antibody into plerocercoids by 
cultivation with various concentrations of the antibody. 
Vertical bars represent standard deviation. 
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Fig. 8. Elution profile obtained from gel filtration of the worm extract of 










単位とした.また， cathepsin-L様活性は， 5.0 
mgのazocollをO.1 M CH:lCOONa buffer pH 5.4 
に溶解し，抽出液のazocoll水解活性を吸光度540
nmで測定した.虫体抽出液を0.3羽 NaC1加25
mM Tris-HC1 buffer pH 7.4で平街化した
TOYOPEARL HW-55カラム(TosohCo.)にてゲ












































Fig. 9. Elution profiles of enzymes in the worm extract obtained from gel filtration 












P、J¥.0 F F . ¥.0 
280 nm: PI悦 einconcentration， 540 nm: Unit of azocoll hydro1yzing activity， unit: unit 










Fig. 10. Elution profile of the trypsin inhibitor isolated by gel filtration on a column 
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Fig. 11.日utionprofile of the trypsin inhibitor on a column of Superdex村R75. 
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Fig. 12. SDS-PAGE of the trypsin inhibitor. 
5 
Lane 1: calibration proteins， Lane 2: crude worm extract， Lane 3: trypsin inhibitor 
isolated by g巴1filtration， Lane 4: trypsin inhibitor isolated by MonoQ， Lane 5: 
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Fig. 13. Immunoblot analysis of the trypsin inhibitor using anti-27. 5 kDa protein 
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